134 related articles for article (PubMed ID: 8797696)
1. Findings from the Miyazaki Cohort Study.
Mueller N; Okayama A; Stuver S; Tachibana N
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S2-7. PubMed ID: 8797696
[TBL] [Abstract][Full Text] [Related]
2. Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica.
Birmann BM; Breen EC; Stuver S; Cranston B; MartÃnez-Maza O; Falk KI; Okayama A; Hanchard B; Mueller N; Hisada M
Int J Cancer; 2009 Feb; 124(3):614-21. PubMed ID: 18989900
[TBL] [Abstract][Full Text] [Related]
3. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors.
Satake M; Yamaguchi K; Tadokoro K
J Med Virol; 2012 Feb; 84(2):327-35. PubMed ID: 22170555
[TBL] [Abstract][Full Text] [Related]
4. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
5. HTLV-1 infection in a population-based cohort of older persons in Guinea-Bissau, West Africa: risk factors and impact on survival.
Melbye M; Poulsen AG; Gallo D; Pedersen JB; Biggar RJ; Larsen O; Dias F; Aaby P
Int J Cancer; 1998 May; 76(3):293-8. PubMed ID: 9579561
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of morbidity among human T lymphotropic virus type 1 carriers in Miyazaki, Japan.
Stuver SO; Tachibana N; Okayama A; Mueller NE
J Infect Dis; 1996 Mar; 173(3):584-91. PubMed ID: 8627021
[TBL] [Abstract][Full Text] [Related]
7. Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers.
Hisada M; Stuver SO; Okayama A; Li HC; Sawada T; Hanchard B; Mueller NE
J Infect Dis; 2004 Nov; 190(9):1605-9. PubMed ID: 15478065
[TBL] [Abstract][Full Text] [Related]
8. A high prevalence of human T-lymphotropic virus type I carriers in patients with antithyroid antibodies.
Mizokami T; Okamura K; Ikenoue H; Sato K; Kuroda T; Maeda Y; Fujishima M
Thyroid; 1994; 4(4):415-9. PubMed ID: 7711504
[TBL] [Abstract][Full Text] [Related]
9. Viral-specific humoral immune responses following transfusion-related transmission of human T cell lymphotropic virus type-I infection.
Manns A; Wilks RJ; Hanchard B; Morgan OS; Rudolph DL; Lal RB
Viral Immunol; 1994; 7(3):113-20. PubMed ID: 7598784
[TBL] [Abstract][Full Text] [Related]
10. [An epidemiologic study of anti-HTLV-I (antibody to human T cell lymphotropic virus type I) by category of disease in the Kushima district of Miyazaki prefecture].
Hirata M; Kajiyama W; Nakashima K; Noguchi A; Hayashi J; Kashiwagi S; Tanimura N; Shingu T
Kansenshogaku Zasshi; 1991 Feb; 65(2):162-7. PubMed ID: 2066597
[TBL] [Abstract][Full Text] [Related]
11. Risk of bronchioloalveolar carcinoma in patients with human T-cell lymphotropic virus type 1 (HTLV-I): case-control study results.
Nomori H; Mori T; Iyama K; Okamoto T; Kamakura M
Ann Thorac Cardiovasc Surg; 2011; 17(1):19-23. PubMed ID: 21587123
[TBL] [Abstract][Full Text] [Related]
12. Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group.
Kaplan JE; Khabbaz RF; Murphy EL; Hermansen S; Roberts C; Lal R; Heneine W; Wright D; Matijas L; Thomson R; Rudolph D; Switzer WM; Kleinman S; Busch M; Schreiber GB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):193-201. PubMed ID: 8680892
[TBL] [Abstract][Full Text] [Related]
13. Vertical transmission of HTLV-I/II: a review.
Bittencourt AL
Rev Inst Med Trop Sao Paulo; 1998; 40(4):245-51. PubMed ID: 9876439
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology of human T lymphotropic virus type 1 transmission in Okinawa, Japan.
Kakuda K; Ikematsu H; Chong WL; Hayashi J; Kashiwagi S
Am J Trop Med Hyg; 2002 Apr; 66(4):404-8. PubMed ID: 12164296
[TBL] [Abstract][Full Text] [Related]
15. [Vertical transmission human T-cell lymphotropic virus type-I (HTLV-I)--genetic diagnosis and assessment of the probable routes of HTLV-I infection].
Ikeda K; Inaba N; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1283-8. PubMed ID: 7903107
[TBL] [Abstract][Full Text] [Related]
16. Antibody to p40tax protein of human T cell leukemia virus 1 and infectivity.
Kashiwagi S; Kajiyama W; Hayashi J; Noguchi A; Nakashima K; Nomura H; Ikematsu H; Sawada T; Kida S; Koide A
J Infect Dis; 1990 Mar; 161(3):426-9. PubMed ID: 2313123
[TBL] [Abstract][Full Text] [Related]
17. Rate of positive autoimmune markers in Human T lymphotropic virus type 1 carriers: a case-control study from Iran.
Ahmadi Ghezeldasht S; Hedayati-Moghaddam MR; Habibi M; Mollahosseini F; Rafatpanah H; Miri R; Hatef Fard M; Sahebari M
Int J Rheum Dis; 2018 Jan; 21(1):108-113. PubMed ID: 28261958
[TBL] [Abstract][Full Text] [Related]
18. Patterns of serum type 1 and type 2 immune markers in healthy carriers of HTLV-I.
Birmann BM; Mueller NE; Okayama A; Hsieh CC; Tsubouchi H; Harn D; Stuver SO
J Med Virol; 2006 Jun; 78(6):847-52. PubMed ID: 16628590
[TBL] [Abstract][Full Text] [Related]
19. Human T-Lymphotropic Virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study.
Einsiedel L; Woodman RJ; Flynn M; Wilson K; Cassar O; Gessain A
BMC Public Health; 2016 Aug; 16():787. PubMed ID: 27526923
[TBL] [Abstract][Full Text] [Related]
20. Case-control study of factors associated with human T-cell leukemia virus type I infection in southern Miyazaki, Japan.
Stuver SO; Tachibana N; Mueller N
J Natl Cancer Inst; 1992 Jun; 84(11):867-72. PubMed ID: 1593654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
